News, Analysis & Insights on Nutrition, Supplements, and Health
Canadian krill oil firm Neptune Technologies & Bioressources posted a modest rise in revenues in the first quarter of 2012 but said its bottom line had suffered owing to changes in exchange rates, a switch to International Financial Reporting Standards...
Stabilized rice bran (SRB) supplier NutraCea has narrowed its loss in the second quarter of 2011 and increased revenues 29 percent, although sales of rice bran for food and feed applications did not grow as quickly as anticipated, the company said.
An extract from Caralluma fimbriata may inhibit the ability of pre-fat cells to develop into mature fat cells, says a new cell study from an international team of researchers.
Aker BioMarine is aiming to launch a novel powdered product from Antarctic krill “without using expensive and dilutive microencapsulation technology” by the end of this year.
Profits have surged 60% at Swedish probiotics player BioGaia as its focus on the medical channel sees its business growing in all markets, with Italy and Japan gaining special mention.
Birds Eye has slammed a "ridiculous" UK Advertising Standards Authority (ASA) ruling that two of its frozen foods adverts made forbidden comparative nutrition claims.
Irish dairy and ingredients group Kerry has turned in a”solid” first half of 2011 that saw it increase volumes, weather raw material price hikes, and see success in a “go-to-market” functional ingredient strategy as profits jumped 6.1% on 2010 figures.
Infant milks for over-1s are not better than regular cow’s milk, a German government agency has found after analysing their nutritional properties.
Algae Biosciences Corporation – a high-profile new entrant to the omega-3 fatty acid market – has unveiled detailed figures on anticipated production volumes after finalizing a deal to build the first phase of its new production facility near Holbrook in...
Three more firms have followed Cargill’s lead and submitted petitions to the FDA urging it to rethink plans to amend the criteria for making health claims about phytosterols and heart disease or risk causing “irreparable injury”.